Grantees
Our comprehensive, hypothesis-driven approach breaks down barriers between innovation, scientific findings, and clinical care. Our grantees support and drive our mission to help everyone with bipolar disorder thrive.
Grantee Projects
Showing 14 of 14 results.
BD² Integrated Network – Brigham and Women’s Hospital-McLean Hospital
Northeastern USBD² Integrated Network – Johns Hopkins University
Southern USBD² Integrated Network – Mayo Clinic
Midwestern USBD² Integrated Network – University of California, Los Angeles
Western USBD² Integrated Network – University of Michigan
Midwestern USBD² Integrated Network – UTHealth Houston
Southern USBD² Integrated Network Clinical Coordinating Center (CCC)
The Feinstein Institutes for Medical ResearchBD² Integrated Network Data Coordinating Center & Centralized Repository (DCC)
Indoc ResearchBipolar Disorder Genes In Brain Circuits Controlling Sleep and Wake Cycles
Julie Kauer, PhDTeam Institutions
- Stanford University
- Northwestern University
- University of Texas Austin
Brain Omics Platform
The CommonMind ConsortiumTeam Institutions
- Icahn School of Medicine at Mount Sinai
- University of Pittsburgh
- California Institute of Technology
CircaVent: A Drug Prediction and Discovery Platform for Bipolar Disorder
Jenny Tam, PhDTeam Institution
- Wyss Institute at Harvard University
Examining Convergent Mechanisms Through Stem Cells
Thomas Lehner, PhD, MPHTeam Institutions
- New York Genome Center
- Rutgers University
- Columbia University
- New York University
- KTH Royal Institute of Technology
Genetics Platform
The Broad Institute of MIT and HarvardTeam Institutions
- The Broad Institute of MIT and Harvard
- University of California, Los Angeles
- New York Genome Center
Identifying Novel Mitochondrial Mechanisms in Bipolar Disorder
Hilary Blumberg, MDTeam Institution
- Yale University